368
Bearbeitungen
Zeile 134: | Zeile 134: | ||
|- | |- | ||
|1. Wahl | |1. Wahl | ||
| | |Levofloxacin | ||
| | |1x 750mg po | ||
| 7-10 d | | 7-10 d | ||
|DANI GFR > | |DANI GFR > 50: 100% | ||
|- | |- | ||
|Alternative | |Alternative | ||
| | |Cefpodoxim | ||
| | | 2x 200mg po | ||
|7-10 d | |7-10 d | ||
| | |CAVE: kann zu vermehrten Auftreten von ESBL-Bildnern kommen. | ||
Beachte zudem Enterokokken-Lücke der Cephalosporine! | |||
|- | |- | ||
|Alternative | |Alternative | ||
| | |Ciprofloxacin | ||
|2x | |2x 500mg po | ||
|7-10 d | |7-10 d | ||
| | |DANI GFR > 60: 100% | ||
|} | |} | ||